It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Feasibility and efficacy of complex percutaneous coronary intervention (PCI) in the elderly, a more frail population due to more comorbidities is incompletely understood. We therefore set out to compare success and complication rate of PCI for chronic total occlusion (CTO) in octogenarians, in comparison to non-octogenarians. Data from 267 patients (58 patients over 80 years of age and 209 under 80 years of age) who had undergone CTO PCI were analyzed. To compare the results we calculated the propensity score and used inverse probability of treatment weighting. We evaluated demographic, clinical, angiographic, and periprocedural information. The median age of the total collective was 68 (31–90) years (octogenarian collective 82 (80–90) years vs non-octogenarians 65 (31–79) years). We observed a high success rate in both collectives (82.8% vs 90.4%, p = 0.10) and no difference in periprocedural complications or complications in the follow-up period. In our collective restenosis rate at follow-up was comparable to the propensity sore weighted population (11.3% vs 16.3%, p = 0.9). Our results show that CTO PCI in older patients is safe and feasible with comparable in-hospital and follow-up complication rates compared to a younger patient population.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details

1 Johannes Gutenberg University, Department of Cardiology, University Medical Center Mainz - Center of Cardiology, Mainz, Germany (GRID:grid.5802.f) (ISNI:0000 0001 1941 7111)
2 Johannes Gutenberg University, Department of Cardiology, University Medical Center Mainz - Center of Cardiology, Mainz, Germany (GRID:grid.5802.f) (ISNI:0000 0001 1941 7111); Johannes Gutenberg University, Center for Thrombosis and Hemostasis (CTH), Mainz, Germany (GRID:grid.5802.f) (ISNI:0000 0001 1941 7111)
3 Goethe University Frankfurt, Department of Cardiology, Center of Internal Medicine, Frankfurt, Germany (GRID:grid.7839.5) (ISNI:0000 0004 1936 9721)
4 Johannes Gutenberg University, Department of Cardiology, University Medical Center Mainz - Center of Cardiology, Mainz, Germany (GRID:grid.5802.f) (ISNI:0000 0001 1941 7111); Partner Site Rhine-Main, German Center for Cardiovascular Research (DZHK), Mainz, Germany (GRID:grid.452396.f) (ISNI:0000 0004 5937 5237)
5 Johannes Gutenberg University, Department of Cardiology, University Medical Center Mainz - Center of Cardiology, Mainz, Germany (GRID:grid.5802.f) (ISNI:0000 0001 1941 7111); Partner Site Rhine-Main, German Center for Cardiovascular Research (DZHK), Mainz, Germany (GRID:grid.452396.f) (ISNI:0000 0004 5937 5237); Johannes Gutenberg University, Center for Thrombosis and Hemostasis (CTH), Mainz, Germany (GRID:grid.5802.f) (ISNI:0000 0001 1941 7111)